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Background and purpose
Recent studies of injection drug users (IDUs) in Puerto
Rico indicate widespread use of xylazine, also known as
horse anesthesia (a veterinary analgesic sedative) mixed
with heroin and cocaine. Research shows that xylazine
contributes to more severe symptoms of withdrawal.
This study explored the association between the use of
heroin+xylazine and poor health outcomes, including
hepatitis C and HIV risk among Puerto Rican drug users.
Methods
Data from 451 Puerto Rican drug users were gathered by
bilingual Spanish and English in-person surveys between
2007 and 2013. Study participants were recruited in areas
of San Juan, Rio Piedras, and Ponce where drug users
were known to gather. Study eligibility was verified by
screening their age (18 or older) and current substance
use. Participants received a code based on date of birth
and mother’s name to prevent the same respondent from
taking the survey multiple times. The study included ques-
tions from the Substance Abuse Mental Health Services
Administration, Government Performance and Results
Act questionnaire and a revised National Institute on
Drug Abuse-validated Addiction Risk Behavior Assess-
ment battery. The questionnaire was translated to Spanish,
back-translated, and adapted for Puerto Ricans. Bivariate
analyses explored the association between heroin+xylazine
use and poor health outcomes (self-reported poor health
status, being diagnosed with hepatitis C, and HIV risk
behaviors). Logistic regression analysis compared the risks
associated with using heroin+xylazine and health
outcomes, controlling for demographic factors that were
significant at the bivariate level.
Results
Incidence of having injected heroin+xylazine were high
(73.4%) and 67.4 percent of the sample had injected
xylazine mixed with heroin within 30 days of the inter-
view. Seventy-nine percent of IDUs were male; 54 per-
cent did not have a high school diploma, and 81 percent
were homeless or in temporary housing. Heroin+xyla-
zine users were more likely to report lower health sta-
tus, stating poor or fair health as opposed to good or
excellent health (OR = 2.85; CI 1.22–6.66) than those
who had never used heroin+xylazine (p < .05). Xylazine
mix users were also more likely to report being diag-
nosed with hepatitis C (OR = 1.90; CI 1.13 – 3.18; p <
.05). Substance users who mixed xylazine+heroin were
also significantly more likely to have participated in HIV
risk behaviors such as injecting more than 5x/day (OR =
9.571; CI 4.72 –19.39); p < .001), sharing works (OR =
2.73; CI 1.34–5.57; p < .05), injecting others (OR = 5.79;
CI 2.59–12.98; p = .001), and being injected by others
(OR = 5.27; CI 2.36–11.77; p < .001).
Conclusions and implications
Self-reported poor health outcomes and HIV risk beha-
viors are significantly associated with heroin+xylazine
use. The migratory pattern of Puerto Rican IDUs travel-
ing to and from the USA mainland, possibly carrying
xylazine, will likely increase the need for HIV, substance
abuse, and hepatitis C prevention efforts in both geo-
graphic locations.
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